New Programme

Postgraduate Programme in Navigating Immunotherapy

Duration: 6 weeks

ICGP and NMBI

Fully funded by MSD for Irish HCWs

The comprehensive online educational programme, developed by iheed, supported by MSD and accredited by professional bodies, is designed to address the educational gap in immuno-oncology and immune- related adverse event (irAE) management.

Google Logo
4.8+

Based on 120+ reviews

Postgraduate Programme in Navigating Immunotherapy Image

Programme Details


Offered free of charge, the course focuses on best practices in the recognition and management of irAEs. Engaging and interactive, the programme combines self-paced e-learning, discussion forums, and live workshops facilitated by subject experts

Immunotherapy represents a groundbreaking approach to cancer treatment, utilizing the body’s immune system to target and eliminate cancer cells. This innovative therapy offers promising outcomes for various cancer types and has become an increasingly significant component of modern cancer care. As immunotherapy continues to evolve, understanding its mechanisms, applications, and potential complications becomes crucial for healthcare professionals to provide effective patient care and support.

While effective, Immunotherapy can sometimes lead to immune-related adverse events (irAEs) due to the immune system’s heightened activity. Managing irAEs is essential to ensure patient safety and treatment efficacy. Effective management involves early identification, prompt intervention, and continuous monitoring. 

A world-class online learning experience

A world-class online learning experience

This online interactive programme will be delivered fully online through a stimulating learning environment that has: 

  • Rich engaging and interactive content designed to maximise interaction

  • Tutor moderated discussion forums

  • Live weekly online tutorials

  • Interactive case based learning

  • Access to an extensive online library, journals and formularies

Who is this programme for?

Who is this programme for?

This programme targets General Practitioners, Non-Consultant Hospital Doctors, Nurses, and Pharmacists who are not oncology specialists but are involved in the care of cancer patients undergoing immunotherapy. 

Upon completion of the programme, participants will be equipped with a solid understanding of immunotherapy treatments and a greater ability to identify irAEs effectively. 

Programme Overview

It aims to empower these healthcare professionals with the knowledge and skills needed to effectively identify and respond to irAEs, improving patient care and fostering interdisciplinary collaboration.

Programme Modules:

  • Understanding Immunotherapy 

  • Patient Journey